We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Tuberculosis FREE

Ann R. Punnoose, MD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2013;309(9):938. doi:10.1001/2012.jama.10804.
Text Size: A A A
Published online

Tuberculosis (TB) is a communicable infection (can be transmitted from person to person) that usually affects the lungs. It is spread by airborne droplets when an infected person coughs or sneezes. It is caused by a bacterium called Mycobacterium tuberculosis. At the time of diagnosis, people with TB usually have a variety of symptoms such as low-grade fever, constant cough with sputum (phlegm), night sweats, and unintentional weight loss.


  • Active TB describes an ongoing infection in which a person develops symptoms and has a positive (abnormal) result on a test for TB.

  • Latent TB occurs when a person with no symptoms has a positive result on a TB skin or blood test. This suggests that the person was infected with TB in the past but the bacteria are in a dormant or inactive state. Persons with latent TB cannot spread the TB bacteria to others.

  • Multidrug-resistant TB (MDR-TB) is a form of active TB caused by bacteria that do not respond to the medications most commonly used to treat TB.


  • A deficient or weakened immune system, such as in people with diabetes or HIV/AIDS

  • Traveling to or living in countries where tuberculosis is endemic (found commonly)

  • Working in health care or refugee camps

  • Living in overcrowded and poorly ventilated residences


  • Tuberculin skin test (also called PPD, or purified protein derivative). In response to this injection, if a person has been infected with TB, immune cells will indurate (harden) the area surrounding the injection site. The area of induration is measured 48 to 72 hours after injection and used to determine the likelihood of TB infection.

  • Chest x-ray may be done to distinguish between active and latent TB.

  • A blood test may be done to check for cytokines (substances released by immune cells) that are unique to TB infections.


  • Several antimicrobials (medicines that kill microorganisms or interfere with their growth) are used to treat tuberculosis.

  • Treatment usually lasts for 6 months and requires close monitoring by an infectious diseases specialist or other specialist.

  • Complete treatment of a person with any form of TB is essential to maintain the person's health and to prevent the spread of tuberculosis to others.


  • In high-risk health care settings, appropriate precautions should be followed. This includes wearing masks specifically designed to prevent the spread of TB.

  • Patients diagnosed as having latent TB may be given medications to kill dormant bacteria and prevent the development of active TB.

  • In countries where TB is endemic, people may be given bacille Calmette-Guérin (BCG), a vaccine against TB.



To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA 's website at www.jama.com. Many are available in English and Spanish.

Source: US Centers for Disease Control and Prevention

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Spanish Patient Page: Tuberculosis

Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Promoción de la salud en el ciclo de vida

Promoción de la salud en el ciclo de vida